stockrowADC Therapeutics SA (ADCT) vs Emergent Biosolutions Inc. (EBS)
- ADC Therapeutics SA ADCT 1.66 −3.49%
- Emergent Biosolutions Inc. EBS 5.92 +0.34%
ADC Therapeutics SA and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $300.8M against $209.4M — 1.4× the size. ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −17.7%. Emergent Biosolutions Inc. has the higher net margin (−40.2% vs −121.8%) and the lower return on invested capital (−17.5% vs 0.00%). Across the 18 metrics below, ADC Therapeutics SA leads on 9 and Emergent Biosolutions Inc. on 9.
Valuation
Profitability
| Metric | ADCT | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 88.86% | 48.42% | 53.51% |
| Operating margin | (125.08%) | (27.70%) | 0.00% |
| Net margin | (121.77%) | (40.16%) | (2.45%) |
| Free cash flow margin | (127.72%) | 29.89% | 0.00% |
| Return on equity | 45.35% | (58.21%) | (0.80%) |
| Return on assets | (32.25%) | (21.23%) | (1.67%) |
| Return on invested capital | 0.00% | (17.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack